Bilaketaren emaitzak - Samuel A. Funt

Findu emaitzak
  1. 1
    The Role of Neoadjuvant Trials in Drug Development for Solid Tumors

    The Role of Neoadjuvant Trials in Drug Development for Solid Tumors nork Samuel A. Funt, Paul B. Chapman

    Argitaratua 2016
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Systemic, perioperative management of muscle-invasive bladder cancer and future horizons

    Systemic, perioperative management of muscle-invasive bladder cancer and future horizons nork Samuel A. Funt, Jonathan E. Rosenberg

    Argitaratua 2016
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Pegylation of High-Density Lipoprotein Decreases Plasma Clearance and Enhances Antiatherogenic Activity

    Pegylation of High-Density Lipoprotein Decreases Plasma Clearance and Enhances Antiatherogenic Activity nork Andrew Murphy, Samuel A. Funt, Darren J. Gorman, Alan R. Tall, Nan Wang

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer

    The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer nork Nick van Dijk, Samuel A. Funt, Christian U. Blank, Thomas Powles, Jonathan E. Rosenberg, Michiel S. van der Heijden

    Argitaratua 2018
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes

    Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes nork Alexander Solovyov, Nicolas Vabret, Kshitij S. Arora, Alexandra Snyder, Samuel A. Funt, Dean F. Bajorin, Jonathan E. Rosenberg, Nina Bhardwaj, David T. Ting, Benjamin D. Greenbaum

    Argitaratua 2018
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors

    Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors nork Samuel A. Funt, Sujata Patil, Darren R. Feldman, Robert J. Motzer, Dean F. Bajorin, Joel Sheinfeld, Satish K. Tickoo, Victor E. Reuter, George J. Bosl

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Role of Interleukin 17 in Inflammation, Atherosclerosis, and Vascular Function in Apolipoprotein E–Deficient Mice

    Role of Interleukin 17 in Inflammation, Atherosclerosis, and Vascular Function in Apolipoprotein E–Deficient Mice nork Meena S. Madhur, Samuel A. Funt, Li Li, Antony Vinh, Wei Chen, Heinrich E. Lob, Yoichiro Iwakura, Yelena Blinder, Ayaz Rahman, Arshed A. Quyyumi, David G. Harrison

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Pretreatment Eosinophil Counts in Patients With Advanced or Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1 Checkpoint Inhibitors

    Pretreatment Eosinophil Counts in Patients With Advanced or Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1 Checkpoint Inhibitors nork José Maurício Mota, Min Yuen Teo, Karissa Whiting, Han A. Li, Ashely M. Regazzi, Chung‐Han Lee, Samuel A. Funt, Dean F. Bajorin, Irina Ostrovnaya, Gopa Iyer, Jonathan E. Rosenberg

    Argitaratua 2021
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation

    Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation nork Mohamed A. Saleh, William G. McMaster, Jing Wu, Allison E. Norlander, Samuel A. Funt, Salim Thabet, Annet Kirabo, Liang Xiao, Wei Chen, Hana A. Itani, Danielle L. Michell, Tianxiao Huan, Xiaoyan Zhang, Satoshi Takaki, Jens Titze, Daniel Levy, David G. Harrison, Meena S. Madhur

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology

    PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology nork Henning Reis, Rene Serrette, Jennifer Posada, Vincent Lu, Ying‐Bei Chen, Anuradha Gopalan, Samson W. Fine, Satish K. Tickoo, S. Joseph Sirintrapun, Gopa Iyer, Samuel A. Funt, Min Yuen Teo, Jonathan E. Rosenberg, Dean F. Bajorin, Guido Dalbagni, Bernard H. Bochner, David B. Solit, Victor E. Reuter, Hikmat Al‐Ahmadie

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Escape from nonsense-mediated decay associates with anti-tumor immunogenicity

    Escape from nonsense-mediated decay associates with anti-tumor immunogenicity nork Kevin Litchfield, James L. Reading, Emilia L. Lim, Hang Xu, Po Liu, Maise Al-Bakir, Yien Ning Sophia Wong, Andrew Rowan, Samuel A. Funt, Taha Merghoub, David Perkins, Martin Lauss, Inge Marie Svane, Göran Jönsson, Javier Herrero, James Larkin, Sergio A. Quezada, Matthew D. Hellmann, Samra Turajlic, Charles Swanton

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis

    Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis nork Alexandra Snyder, Tavi Nathanson, Samuel A. Funt, Arun Ahuja, Jacqueline L. Buros, Matthew D. Hellmann, Eliza Chang, Bülent Arman Aksoy, Hikmat Al‐Ahmadie, Erik Yusko, Marissa Vignali, Sharon Benzeno, Mariel Elena Boyd, Meredith Moran, Gopa Iyer, Harlan Robins, Elaine R. Mardis, Taha Merghoub, Jeff Hammerbacher, Jonathan E. Rosenberg, Dean F. Bajorin

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers

    Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers nork Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, Ashley Marie Regazzi, Brooke Kania, Meredith Moran, C Cipolla, Mark J. Bluth, Joshua Chaim, Hikmat Al‐Ahmadie, Alexandra Snyder, Maria I. Carlo, David B. Solit, Michael F. Berger, Samuel A. Funt, Jedd D. Wolchok, Gopa Iyer, Dean F. Bajorin, Margaret K. Callahan, Jacob Rosenberg

    Argitaratua 2018
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies

    IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies nork Dulce M. Barrios, Gregory S. Phillips, Amaris Geisler, Sabrina Trelles, Alina Markova, Sarah Noor, Elizabeth Quigley, Helen Haliasos, Andrea P. Moy, Alison M. Schram, J. Bromberg, Samuel A. Funt, Martin H. Voss, Alexander Drilon, Matthew D. Hellmann, Elizabeth Comen, Saisindhu Narala, Anisha B. Patel, Megan Wetzel, Jae Yeon Jung, Donald Y.M. Leung, Mario E. Lacouture

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy

    Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy nork Eugene J. Pietzak, Emily C. Zabor, Aditya Bagrodia, Joshua Armenia, Wenhuo Hu, Ahmet Zehir, Samuel A. Funt, François Audenet, David Barron, Noelia Maamouri, Qiang Li, Min Yuen Teo, Maria E. Arcila, Michael F. Berger, Nikolaus Schultz, Guido Dalbagni, Harry W. Herr, Dean F. Bajorin, Jonathan E. Rosenberg, Hikmat Al‐Ahmadie, Bernard H. Bochner, David B. Solit, Gopa Iyer

    Argitaratua 2018
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma

    Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma nork Jeppe Sejerø Holm, Samuel A. Funt, Annie Borch, Kamilla Kjærgaard Munk, Anne-Mette Bjerregaard, James L. Reading, Colleen Maher, Ashley Marie Regazzi, Phillip Wong, Hikmat Al‐Ahmadie, Gopa Iyer, Tripti Tamhane, Amalie Kai Bentzen, Nana Overgaard Herschend, Susan De Wolf, Alexandra Snyder, Taha Merghoub, Jedd D. Wolchok, Morten Nielsen, Jonathan E. Rosenberg, Dean F. Bajorin, Sine Reker Hadrup

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade

    LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade nork Ronglai Shen, Michael A. Postow, Matthew Adamow, Arshi Arora, Margaret Hannum, Colleen Maher, Phillip Wong, Michael A. Curran, Travis J. Hollmann, Liwei Jia, Hikmat Al‐Ahmadie, Niamh M. Keegan, Samuel A. Funt, Gopa Iyer, Jonathan E. Rosenberg, Dean F. Bajorin, Paul B. Chapman, Alexander N. Shoushtari, Allison Betof Warner, Parisa Momtaz, Taha Merghoub, Jedd D. Wolchok, Katherine S. Panageas, Margaret K. Callahan

    Argitaratua 2021
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition

    IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition nork Annie Borch, Ibel Carri, Birkir Reynisson, Heli M. Garcia Alvarez, Kamilla Kjærgaard Munk, Alessandro Montemurro, Nikolaj Pagh Kristensen, Siri Tvingsholm, Jeppe Sejerø Holm, Christina Heeke, Keith Moss, Ulla Kring Hansen, Anna‐Lisa Schaap‐Johansen, Frederik Otzen Bagger, Vinicius Araújo Barbosa de Lima, Kristoffer Staal Rohrberg, Samuel A. Funt, Marco Donia, Inge Marie Svane, Ulrik Lassen, Carolina Barra, Morten Nielsen, Sine Reker Hadrup

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor

    Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor nork Justin Taylor, Mark T.A. Donoghue, Caleb Ho, Kseniya Petrova‐Drus, Hikmat Al‐Ahmadie, Samuel A. Funt, Yanming Zhang, Umut Aypar, Pavitra Rao, Shweta S. Chavan, Michael Haddadin, Roni Tamari, Sergio Giralt, Martin S. Tallman, Raajit K. Rampal, Priscilla Baez, Rajya Kappagantula, Satyajit Kosuri, Ahmet Doǧan, Satish K. Tickoo, Victor E. Reuter, George J. Bosl, Christine A. Iacobuzio‐Donahue, David B. Solit, Barry S. Taylor, Darren R. Feldman, Omar Abdel‐Wahab

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Fundamental immune–oncogenicity trade-offs define driver mutation fitness

    Fundamental immune–oncogenicity trade-offs define driver mutation fitness nork David Hoyos, Roberta Zappasodi, Isabell Schulze, Zachary Sethna, Kelvin C. de Andrade, Dean F. Bajorin, Chaitanya Bandlamudi, Margaret K. Callahan, Samuel A. Funt, Sine Reker Hadrup, Jeppe Sejerø Holm, Jonathan E. Rosenberg, Sohrab P. Shah, Ignacio Vázquez-Garćıa, Britta Weigelt, Michelle Wu, Dmitriy Zamarin, Laura F. Campitelli, Edward J. Osborne, Mark Klinger, Harlan Robins, Payal P. Khincha, Sharon A. Savage, Vinod P. Balachandran, Jedd D. Wolchok, Matthew D. Hellmann, Taha Merghoub, Arnold J. Levine, Marta Łuksza, Benjamin D. Greenbaum

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: